Andere Sprachen Paragon 28, Inc.

Aktien

A3C5FT

US69913P1057

FNA

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 03.05.2024			% 5 Tage	% 1. Jan.
10,53 ^USD	+7,78 %		+19,66 %	-15,29 %

04.04.	Sektor-Update: Aktien des Gesundheitswesens fallen am späten Nachmittag	MT
04.04.	Sektor Update: Gesundheitswesen	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Paragon 28 to Present at the Bank of America Securities 2024 Healthcare Conference	02.05.
Sector Update: Health Care Stocks Slump Late Afternoon	04.04.
Sector Update: Health Care	04.04.
Paragon 28 Shares Slump After Announcing Preliminary Q1 Revenue, CFO Resignation	04.04.
Paragon 28 Announces CFO Transition, Provides Preliminary Unaudited Net Revenue for First Quarter 2024, and Reaffirms Net Revenue Guidance for Fiscal Year 2024	04.04.
Paragon 28, Inc. Reaffirms Net Revenue Guidance for Fiscal Year 2024	04.04.
Paragon 28, Inc. Announces Chief Financial Officer Changes	04.04.
Paragon 28, Inc. Announces Board Changes	04.04.
Paragon 28, Inc. Provides Revenue Guidance for the First Quarter 2024	04.04.
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System	28.03.
Paragon 28, Inc. Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler®? R3INFORCE?? Extraosseous Repair System	28.03.
Paragon 28 Insider Bought Shares Worth $255,226, According to a Recent SEC Filing	19.03.
Paragon 28 Narrows Q4 Loss, Revenue Increases; Sets 2024 Outlook	29.02.
Paragon 28 Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Net Revenue Guidance	29.02.
Earnings Flash (FNA) PARAGON 28 Reports Q4 Revenue $60.6M, vs. Street Est of $60.5M	29.02.
Paragon 28, Inc. Provides Earnings Guidance for the Fiscal Year 2024	29.02.
Paragon 28, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29.02.
Paragon 28, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29.02.
Paragon 28 to Present at the CG 2024 Musculoskeletal Conference	12.02.
Paragon 28 To Report Fourth Quarter and Full Year 2023 Financial Results on February 29, 2024	06.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Paragon 28, Inc.

Aktien

A3C5FT

US69913P1057

FNA

Andere Sprachen

Filter